Rutin-encapsulated manganese carbonate nanoparticles for ‘liver-dark/tumor-bright’ magnetic resonance imaging and inhibition of breast cancer with liver metastases
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 09.03.2026. Verfasst von Lingfeng Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Imaging Key Laboratory of Sichuan Province and School of Medical Imaging, North Sichuan Medical College, Nanchong 637000, China. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Science and Technology, Doctoral Scientific Research Start-up Fund of North Sichuan Medical College.
Abstract (Originalsprache)
Patients with breast cancer liver metastasis (BCLM) have a low survival rate and poor prognosis; thus, early and precise diagnosis and treatment are important. Here, we developed rutin-encapsulated manganese carbonate nanoparticles (RM NPs) for sensitive magnetic resonance imaging (MRI) diagnosis and effective inhibition of BCLM. RM NPs are nanoclusters consisting of manganese carbonate nanocrystals. They have pH-responsive properties and release Mn2+ following their uptake into cells, generating MRI signals. Using a 4T1 mouse liver metastasis model, we demonstrated different uptake rates of RM NPs between normal liver tissue and metastatic tumors. The ‘liver-dark/tumor-bright’ (tumor-to-normal liver contrast ratio reached 219%) phenomenon can be produced using a specific T1WI imaging sequence, which enables precise imaging of submillimeter (less than 1 mm) BCLM. In vitro and in vivo experiments confirmed that because of the rutin sugar groups on the surface of RM NPs, they actively target tumor cells with overexpressed glucose transporters (Gluts). After being taken up by tumor cells, RM NPs release rutin, which induces tumor cell apoptosis by upregulating cleaved cysteine protease-3 and thereby inhibiting tumor cell growth and liver metastasis. Overall, RM NPs can serve as an effective and safe theranostic platform for precise MRI and treatment of BCLM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Imaging Key Laboratory of Sichuan Province and School of Medical Imaging, North Sichuan Medical College, Nanchong 637000, China.
- Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China.
ORCID-Profile: Changqiang Wu
Förderung
- Sichuan Science and Technology
- Doctoral Scientific Research Start-up Fund of North Sichuan Medical College
Zitieren
APA
Zhao, L., Gao, Y., Chen, T., Li, Y., Chen, A., Hou, Z., Pu, Y., Li, W., Li, X., Zhang, X., & Wu, C. (2026). Rutin-encapsulated manganese carbonate nanoparticles for ‘liver-dark/tumor-bright’ magnetic resonance imaging and inhibition of breast cancer with liver metastases. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag049
Vancouver
Zhao L, Gao Y, Chen T, Li Y, Chen A, Hou Z, et al. Rutin-encapsulated manganese carbonate nanoparticles for ‘liver-dark/tumor-bright’ magnetic resonance imaging and inhibition of breast cancer with liver metastases. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag049
BibTeX
@article{Zhao2026,
author = {Zhao, Lingfeng and Gao, Yuanyuan and Chen, Tao and Li, Yongxi and Chen, Aijia and Hou, Zhengju and Pu, Yu and Li, Wenxue and Li, Xinghui and Zhang, Xiaoming and Wu, Changqiang},
title = {Rutin-encapsulated manganese carbonate nanoparticles for ‘liver-dark/tumor-bright’ magnetic resonance imaging and inhibition of breast cancer with liver metastases},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag049}
}
EUVIMED